Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NECAB1 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NECAB1 mRNA | decreases expression | 20382639
|
D016047 |
Zalcitabine |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of NECAB1 mRNA | affects cotreatment|decreases expression | 18606552
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of NECAB1 mRNA | decreases expression | 18035473
|
C514793 |
gp120 protein, Human immunodeficiency virus 1 |
[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of NECAB1 mRNA | affects cotreatment|decreases expression | 18606552
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of NECAB1 mRNA | increases expression | 19270015
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of NECAB1 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
9.88 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.88 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.21 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.95 | 18287403 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
4.37 | 17620307 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.68 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.79 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18775368 18558336 17688650 18396377 19460635 18316065 18177632 18985861 17157402 17507914 16609825 18940202 19232924 20603192 15238991 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.20 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.57 | 8888407 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
1.94 | 20007298 6705139 17173139 20935162 1701930 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.88 | 10591146 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.90 | 20889678 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.61 | 4080065 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.79 | 20734317 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.23 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
5.05 | 7515130 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
11.47 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
11.47 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
12.02 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
12.02 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
11.50 | 11558140 3922381 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
11.50 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
7.08 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
7.08 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
9.70 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
9.70 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
12.53 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
12.53 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
11.84 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
11.84 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
9.41 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
9.41 | 18299183 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.33 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.46 | 8888407 18558336 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
3.84 | 16109766 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.46 | 17457083 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.77 | 17296493 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 17596541 16294345 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.03 | 21047994 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.22 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
2.39 | 19812893 15975961 19073162 19482888 21047994 8742319 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
2.86 | 18308698 17172636 2563599 1399818 6150874 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.70 | 17228818 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
4.83 | 9488045 11980663 18798262 17941976 8764131 8840982 9205081 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.38 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.31 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.30 | 17596541 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.87 | 17484760 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
5.46 | 9205081 8764131 9488045 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.71 | 17292584 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.30 | 8888407 16359493 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.76 | 17016548 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.57 | 16965848 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
gp120 protein, Human immunodeficiency virus 1 |
12.05 | 18606552 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
12.05 | 18606552 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.87 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.23 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
13.71 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
13.71 | 11422049 12752131 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.48 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.61 | 11442880 4039156 3137016 16876388 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.61 | 1511512 15475178 16876388 11738929 11044598 17978042 3137016 14763951 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.22 | 6407741 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.99 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.98 | 12833885 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.26 | 1399818 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.68 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.92 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.00 | 8888407 |